Moderna Seeks Full Authorization For COVID-19 Vaccine, Will Send Data To FDA

(CBS DETROIT) – Moderna wants full approval from the Food and Drug Administration for its COVID-19 vaccine.

Currently, its vaccine is only authorized for emergency use.

The company says it’ll continue to submit trial data to the FDA on a rolling basis over the next few weeks.

Moderna is the second drugmaker to seek full authorization in the United States for a vaccine.

Pfizer applied for it last month.

© 2021 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.